[Sulpiride: clinical and ambulatory therapy of psychiatric patients and a double blind study of its action spectrum].
D000284:Administration, Oral; D000328:Adult; D001549:Benzamides / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001714:Bipolar Disorder / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D007273:Injections, Intramuscular; D008297:Male; D009497:Neurotic Disorders / Q000188:drug therapy*; D010919:Placebos; D011581:Psychological Tests; D011759:Pyrrolidines / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D012559:Schizophrenia / Q000188:drug therapy*; D014202:Tremor / Q000139:chemically induced
D001549:Benzamides; D010919:Placebos; D011759:Pyrrolidines
Sulpirid: Stationäre und ambulante Behandlung psychiatrischer Patienten und Doppelblinduntersuchung des Wirkungsspektrums.